Exhibitor profile

Curium

ExhibitorRadiopharma DeveloperFind them at SNMMI

Website to be confirmed.

Booth1323

Summary

About Curium

Curium sits in Radiopharma Developer, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

Recent activity

What we're seeing

Imaging Wire · 2026-09-04
Curium closes Series C round to scale radiopharma manufacturing
Coverage notes the company's growing footprint in the radioligand therapy space.
STAT News · 2026-06-27
Curium publishes dosimetry data at SNMMI 2026
Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
Nuclear Medicine Today · 2026-07-10
Curium files IND for next-generation PSMA-targeted agent
The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

Why they're at SNMMI

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.

Bracken's take

A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.

Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.

Similar in this cluster

Companies you may also want to visit.

Booth1231

Actinium Pharmaceuticals

ExhibitorRadiopharma Developer

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Actinium Pharmaceuticals.

View profile →

Booth2222

AtomVie Global Radiopharma Inc.

ExhibitorRadiopharma DeveloperCDMO / CMO

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..

View profile →

Booth2722

Bayer Oncology

ExhibitorRadiopharma Developer

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Bayer Oncology.

View profile →